Kane Biotech Announces Board Members
June 06, 2016 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, MANITOBA--(Marketwired - June 5, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent...
DIAGNOS annonce des changements à son conseil d'administration
May 20, 2016 13:29 ET
|
DIAGNOS inc.
BROSSARD, QUÉBEC--(Marketwired - 20 mai 2016) - DIAGNOS inc. (« DIAGNOS » ou la « Société ») (TSX CROISSANCE:ADK), un leader dans les services...
DIAGNOS Announces Changes to its Board of Directors
May 20, 2016 13:28 ET
|
DIAGNOS Inc.
BROSSARD, QUEBEC--(Marketwired - May 20, 2016) - DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in healthcare technical services including screening, software...
Philip Renaud Files Early Warning Report in Respect of Kane Biotech Inc.
May 05, 2016 18:21 ET
|
Philip Renaud
LONDON, UNITED KINGDOM--(Marketwired - May 5, 2016) - Philip Renaud (11 The Little Boltons, London, England, SW10 9LT), the Chairman and a director of Kane Biotech Inc. (the...
Kane Biotech Announces Rights Offering Closing
May 04, 2016 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, MANITOBA--(Marketwired - May 4, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") is pleased to announce the closing of its rights offering (the...
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
April 07, 2016 12:28 ET
|
Kane Biotech Inc.
WINNIPEG, MANITOBA--(Marketwired - April 7, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on April 7, 2016, it issued 254,369 common shares of the...
Kane Biotech Announces Rights Offering
March 29, 2016 16:52 ET
|
Kane Biotech Inc.
WINNIPEG, MANITOBA--(Marketwired - March 29, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") today announced that it will be offering rights ("Rights") to...
Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
December 31, 2015 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, MANITOBA--(Marketwired - Dec. 31, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation") announced that on December 30, 2015, it issued 251,392 common shares of the...
Philip Renaud Files Updated Early Warning Report in Respect of Kane Biotech Inc.
December 16, 2015 06:00 ET
|
Philip Renaud, Chairman and a Director of Kane Biotech Inc.
LONDON, UNITED KINGDOM--(Marketwired - Dec. 16, 2015) - Philip Renaud, the Chairman and a director of Kane Biotech Inc. (the "Corporation"), today announces that he and the Corporation...
Kane Biotech Announces Amendments to Terms of Convertible Note and Warrants
December 14, 2015 07:00 ET
|
Kane Biotech Inc.
WINNIPEG, MANITOBA--(Marketwired - Dec. 14, 2015) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Corporation" or "Kane Biotech") today announced that the Corporation has entered into an...